Living With Long COVID: LONGCOVID-EXPERIENCE

Living With Long COVID: LONGCOVID-EXPERIENCE Qualitative Study

Background: One in ten people infected with COVID-19 presents persistent COVID, which consists of the presence of symptoms three months after the acute manifestations of COVID-19 and their persistence for at least two months, without being explained by an alternative diagnosis. The characteristics and clinical approach to persistent COVID syndrome are fairly well known, but not what the experience of people with persistent COVID is in relation to their daily life, their work life, and their experience with the healthcare received. Objective: to understand the experience of patients with persistent COVID in relation to the disease, the health care received and re-entry into the world of work

Methods: Qualitative, descriptive, phenomenological study, based on individual interviews. The study protocol will be registered in Clinicaltrials.gov. People with persistent COVID treated at the Parc Taulí Hospital will be included. Sampling will be by convenience, purposive and snowball and the sample size will be determined by data saturation. Semi-structured individual or group interviews will be conducted and the data will be analyzed following a reflective thematic analysis (Brawn and Clarke). The preliminary report will be triangulated with some participants and with the results obtained from a scoping review carried out by the research team.

Study Overview

• Status: Recruiting
• Conditions: Long COVID; Experience, Life

• Study Type: Observational
• Enrollment (Estimated): 25

Contacts and Locations

• Study Contact: Name: Pilar Peña, MD; Phone Number: 82054 +34937231010; Email: ppena@tauli.cat
• Study Contact Backup: Name: Pilar Peña, MD; Phone Number: 82054 +34937231010

Study Locations

• Spain
  • Barcelona
    • Sabadell, Barcelona, Spain, 08208
      • Recruiting
      • Corporació Sanitària Parc Taulí
      • Contact: Pilar Peña, MD, MSci; Phone Number: 22313 937231010; Email: ppena@tauli.cat
      • Contact: Anna Selva, MD, MPH, PhD; Phone Number: 22316 937231010; Email: aselva@tauli.cat

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients treated at the Parc Taulí Hospital Universitari, a hospital with a reference population of 400,000 urban people and 4,500 workers.

Description

Inclusion Criteria:

• women and men diagnosed with persistent COVID between March '20 to the present according to WHO criteria (persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis).
• treated at the Parc Taulí Hospital
• from 18 to 65 years

Exclusion Criteria:

-people who do not understand or can communicate in Catalan or Spanish.

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Persons with- long-covid; Women and men diagnosed with persistent COVID according to WHO (World HEalth Organization) criteria: persistent symptoms three months after the acute manifestations of COVID-19 and lasting at least two months and cannot be explained by an alternative diagnosis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Experience of the disease	How is living with LongCOVID. Assessed through semi-structured interviews.	Up to three years
Experience with healthcare received	How is the experience of patients with the healthcare received for their condition. Assessed through semi-structured interviews.	Up to three years
Experience with return to work	What were the barriers and facilitators for returning to work after the disease. Assessed through semi-structures interviews.	Up to three years

Collaborators and Investigators

• Sponsor: Corporacion Parc Tauli
• Collaborators: Universitat Autonoma de Barcelona
• Investigators: Principal Investigator: Anna Selva, MD, MPH, PhD, Parc Taulí, Hospital Universitari- I3PT; Study Director: Juan Leiva, PhD, Universitat Autònoma Barcelona; Principal Investigator: Pilar Peña, MD, Parc Taulí, Hospital Universitari- I3PT

Study record dates

Study Major Dates

• Study Start (Actual): September 18, 2023
• Primary Completion (Estimated): September 30, 2024
• Study Completion (Estimated): December 30, 2024

Study Registration Dates

• First Submitted: September 15, 2023
• First Submitted That Met QC Criteria: November 3, 2023
• First Posted (Actual): November 7, 2023

Study Record Updates

• Last Update Posted (Actual): November 7, 2023
• Last Update Submitted That Met QC Criteria: November 3, 2023
• Last Verified: November 1, 2023

More Information

Terms related to this study

• Keywords: patient experience; qualitative research; Post-Acute COVID-19 Syndrome
• Additional Relevant MeSH Terms: Pathologic Processes; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; Disease Attributes; Chronic Disease; Post-Infectious Disorders; COVID-19; Post-Acute COVID-19 Syndrome
• Other Study ID Numbers: LONGCOVID EXPERIENCE

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No